Skip to main content
Close Search
search
Menu
No menu assigned
search
Menu
Grab 4Q22: strong execution, EBITDA break-even target brought forward. Buy, $5.50 TP.
Share
Close Menu
Home
Research
Events
Ratings
Team
Contact